share_log

Assure | 8-K: Current report

Assure | 8-K: Current report

Assure | 8-K:重大事件
美股sec公告 ·  05/23 04:11
牛牛AI助理已提取核心訊息
On May 22, 2024, Assure Holdings Corp., a Nevada-based company listed on the NASDAQ Capital Market under the trading symbol IONM, filed a Form 8-K with the United States Securities and Exchange Commission (SEC). The report announced a corporate update call held by Assure and Danam Health, Inc. on the same day. The presentation from the call was filed as Exhibit 99.1 and is incorporated by reference. Assure, which is classified as an emerging growth company, has also filed a registration statement on Form S-4 with the SEC on May 3, 2024, containing a prospectus and a proxy statement in connection with a proposed transaction between Assure and Danam Health Inc. The proxy statement/prospectus will be mailed to stockholders of both companies, and...Show More
On May 22, 2024, Assure Holdings Corp., a Nevada-based company listed on the NASDAQ Capital Market under the trading symbol IONM, filed a Form 8-K with the United States Securities and Exchange Commission (SEC). The report announced a corporate update call held by Assure and Danam Health, Inc. on the same day. The presentation from the call was filed as Exhibit 99.1 and is incorporated by reference. Assure, which is classified as an emerging growth company, has also filed a registration statement on Form S-4 with the SEC on May 3, 2024, containing a prospectus and a proxy statement in connection with a proposed transaction between Assure and Danam Health Inc. The proxy statement/prospectus will be mailed to stockholders of both companies, and the transaction is subject to stockholder approval and other customary closing conditions. The report includes forward-looking statements regarding the proposed transaction, including the anticipated structure, timing, and completion, as well as the expected executive officers and directors of the combined company post-merger. Assure has advised investors and securityholders to read the materials filed with the SEC once available, as they contain important information about the proposed transactions. The documents can be obtained from Assure's website or the SEC's website. The report also contains cautionary statements about potential risks and uncertainties that could affect the actual results and the timing of events related to the proposed transactions.
2024年5月22日,總部位於內華達州的在納斯達克資本市場上市的公司Assure Holdings Corp. 向美國證券交易委員會(SEC)提交了8-K表格。該報告宣佈了Assure和Danam Health, Inc.於當天舉行的公司最新情況電話會議。電話會議上的演示文稿作爲附錄99.1提交,並以引用方式納入。被歸類爲新興成長型公司的Assure也於2024年5月3日向美國證券交易委員會提交了S-4表格的註冊聲明,其中包含與Assure和Danam Health Inc.之間擬議交易有關的招股說明書和委託聲明。委託書/招股說明書將郵寄給兩家公司的股東,該交易需獲得股東批准和其他慣例成交條件...展開全部
2024年5月22日,總部位於內華達州的在納斯達克資本市場上市的公司Assure Holdings Corp. 向美國證券交易委員會(SEC)提交了8-K表格。該報告宣佈了Assure和Danam Health, Inc.於當天舉行的公司最新情況電話會議。電話會議上的演示文稿作爲附錄99.1提交,並以引用方式納入。被歸類爲新興成長型公司的Assure也於2024年5月3日向美國證券交易委員會提交了S-4表格的註冊聲明,其中包含與Assure和Danam Health Inc.之間擬議交易有關的招股說明書和委託聲明。委託書/招股說明書將郵寄給兩家公司的股東,該交易需獲得股東批准和其他慣例成交條件。該報告包括有關擬議交易的前瞻性陳述,包括預期的結構、時間和完成,以及合併後公司的預期執行官和董事。Assure建議投資者和證券持有人閱讀向美國證券交易委員會提交的材料,因爲這些材料包含有關擬議交易的重要信息。這些文件可以從Assure的網站或美國證券交易委員會的網站上獲得。該報告還包含有關潛在風險和不確定性的警示性聲明,這些風險和不確定性可能會影響與擬議交易相關的實際結果和事件發生時間。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。